Home / Resource Library / Low burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options

Low burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options

Study investigated low volume TP53 mutations and its impact on prognosis in CLL.